INVO Fertility, Inc. Cost, Depreciation, Amortization and Depletion
INVO Fertility, Inc. (IVF) reported Cost, Depreciation, Amortization and Depletion of $9.72 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostDepreciationAmortizationAndDepletion · last filed 2021-03-30
- INVO Fertility, Inc. cost, depreciation, amortization and depletion for fiscal 2020 was $9.72K, a 61.92% increase from fiscal 2019.
- INVO Fertility, Inc. cost, depreciation, amortization and depletion for fiscal 2019 was $6.01K.
| Period end | Cost, Depreciation, Amortization and Depletion 12 month |
|---|---|
| 2020-12-31 | $9.72K 10-K · filed 2021-03-30 |
| 2019-12-31 | $6.01K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |